FDA Device Intelligence
HomeDevice types › LOM

Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)

FDA product code LOM · Class 2 · Microbiology

171
Registered devices
3,089
Adverse events
33
Recalls
1
510(k) clearances

Devices with this code

Recent recalls

DateFirmReason
2025-04-24Mckesson Medical-Surgical Inc. Corporate Officetransit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage con
2025-04-24Mckesson Medical-Surgical Inc. Corporate Officetransit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage con
2024-03-01Ortho-Clinical Diagnostics, Inc.Potential for positively biased results due to signal reduction over shelf life.
2023-11-27Ortho-Clinical Diagnostics, Inc.Affected lots may experience increased calibration failures or an increase in falsely elevated results.
2022-12-22Siemens Healthcare Diagnostics, Inc.Anti-HBe2 (aHBe2) interference with the Hepatitis B e Antigen (HBeAg) Assay, leads to elevated or reactive Hepatitis B e Antigen (HBeAg) results on samples that
2018-11-01ORTHO-CLINICAL DIAGNOSTICSThe firm is extending their previous July 2018 recall to include additional product codes. Biased results may occur for these additional products at biotin conc
2018-11-01ORTHO-CLINICAL DIAGNOSTICSThe firm is extending their previous July 2018 recall to include additional product codes. Biased results may occur for these additional products at biotin conc
2018-01-02Siemens Healthcare Diagnostics, Inc.Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista
2018-01-02Siemens Healthcare Diagnostics, Inc.Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista
2014-09-15Siemens Healthcare Diagnostics, IncIncreased imprecision and positive bias is observed with patient samples and negative controls and can result in an increase in initial reactive results.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Sourced from public U.S. FDA data. Informational only — not medical or regulatory advice. Not affiliated with the FDA.